Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLitigation Cap. Regulatory News (LIT)

Share Price Information for Litigation Cap. (LIT)

Share Price is delayed by 15 minutes
Get Live Data
2.70    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.10 (3.846%)
Market Cap: £2.78m
LIT Live PriceLast checked at - London Stock Exchange

Intraday Litigation Cap. Share Chart

Positive development on case

12 Jan 2026 14:07

RNS Number : 5649O
Litigation Capital Management Ltd
12 January 2026
 

12 January 2026

Litigation Capital Management Limited

("LCM" or the "Company")

Positive development on international arbitration claim

 

Litigation Capital Management Limited ("LCM"), an alternative asset manager specialising in dispute financing solutions internationally, announces a positive development in the international arbitration claim against the Republic of Poland (Poland) that it funded. As previously announced on 8 October 2024, the funded party achieved a successful outcome, securing two separate awards - one under the Energy Charter Treaty (ECT) of £252 million plus interest; and one under the Australia-Poland Bilateral Investment Treaty (BIT) of £183 million plus interest. There is no double compensation meaning that total damages cannot exceed £252 million plus interest.

Poland commenced set-aside proceedings in Singapore (ECT) and London (BIT) to attempt to annul the original awards. The Singapore proceedings recently concluded and the Singapore court rejected in its entirety Poland's application to set-aside the ECT award. Poland has a right to an appeal and such an appeal must be filed by 6 February 2026. We anticipate an appeal will be filed and expect the Singapore court to resolve such an appeal in the second half of 2026.

LCM has invested into this case alongside Fund I investors with the total investment being US$11.3m with US$2.8 million coming from LCM's own balance sheet and US$8.5 million from Fund I. LCM's returns are calculated as a rising multiple of invested capital over time plus interest. LCM's contractual entitlement on this case currently stands at approximately US$71.9 million with US$18.0 million of that flowing to LCM shareholders and US$53.9 million flowing to Fund I investors. LCM does not anticipate earning a performance fee from Fund I investors on this case as a result of previously announced adverse case results impacting Fund I. 

Enquiries

Litigation Capital Management

Patrick Moloney, Chief Executive Officer

David Collins, Chief Financial Officer

Cavendish (Nomad and Broker) 

Tel: 020 7220 0500

Jonny Franklin-Adams and Isaac Hooper (Corporate Finance)

Tim Redfern (Corporate Broking)

 

www.lcmfinance.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBTMITMTMBBAF
Date   Source Headline
8th Jul 20227:00 amRNSMarket Update
16th May 20227:00 amRNSLitigation Finance Agreement
4th May 202210:15 amRNSDirector/PDMR Shareholding
25th Apr 20229:30 amRNSDirector/PDMR Shareholding
11th Apr 202211:10 amRNSDirector/PDMR Shareholding
15th Mar 20227:00 amRNSInterim Results
14th Mar 202210:30 amRNSHolding(s) in Company
15th Feb 20227:00 amRNSNotice of Results
14th Feb 20227:00 amRNSMary Gangemi Appointed to the Board
7th Feb 202210:30 amRNSDirector/PDMR Shareholding
1st Feb 202212:45 pmRNSDirector/PDMR Shareholding
4th Jan 20223:58 pmRNSHolding(s) in Company
29th Dec 20214:10 pmRNSDirector/PDMR Shareholding
17th Dec 20217:00 amRNSBoard change
10th Dec 202112:30 pmRNSIssue of Equity and Total Voting Rights
18th Nov 20217:00 amRNSResult of AGM
4th Nov 20217:00 amRNSSuccessful Award in LCIA International Arbitration
29th Oct 20211:24 pmRNSExercise of Options, Equity Issue, Director/PDMR
29th Oct 20211:00 pmRNSIncentive Awards
25th Oct 20217:00 amRNSNotice of AGM
18th Oct 202111:15 amRNSIssue of Equity and Total Voting Rights
14th Oct 20217:00 amRNSLCM Global Alternative Returns Fund II
22nd Sep 202111:20 amRNSHolding(s) in Company
21st Sep 20217:00 amRNSFinal Results 2021
31st Aug 20217:00 amRNSNotice of Results
11th Aug 20217:07 amRNSSuccessful judgment in Australian investment
19th Jul 20217:00 amRNSMarket Update
6th Jul 20217:00 amRNSNew Litigation Finance Agreement
23rd Jun 20217:00 amRNSComet Group liquidation claim
21st Jun 20217:21 amRNSJudgment in New Zealand Investment
27th May 20217:00 amRNSInvestor Presentation
19th May 20217:18 amRNSLitigation Finance Agreement with Carillion
4th May 202112:09 pmRNSHolding(s) in Company
14th Apr 20214:41 pmRNSSecond Price Monitoring Extn
14th Apr 20214:36 pmRNSPrice Monitoring Extension
16th Mar 20217:00 amRNSInterim Results
10th Mar 20216:07 pmRNSIssue of Equity and Total Voting Rights
10th Mar 20215:53 pmRNSHolding(s) in Company
25th Feb 20217:00 amRNSRetail Investor Presentation
22nd Feb 20217:00 amRNSNew US$50m Credit Facility
18th Feb 20212:30 pmRNSHolding(s) in Company
17th Feb 20217:00 amRNSNotice of Results
12th Feb 20215:13 pmRNSHolding(s) in Company
7th Jan 202111:20 amRNSHolding(s) in Company
17th Dec 202012:17 pmRNSHolding(s) in Company
19th Nov 20207:00 amRNSResult of AGM
28th Oct 20207:00 amRNSNotice of Annual General Meeting
15th Oct 202010:30 amRNSIncentive Awards
15th Oct 20207:00 amRNSHolding(s) in Company
23rd Sep 20204:26 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.